Cargando…

Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD – real-life experience from an observational study

BACKGROUND: Long-acting inhaled bronchodilators, including anticholinergic tiotropium, are recommended for the maintenance therapy of chronic obstructive pulmonary disease (COPD). It has been shown in a number of studies that treatment with tiotropium alleviates symptoms, improves exercise tolerance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jahnz-Różyk, Karina, Szepiel, Paweł
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370685/ https://www.ncbi.nlm.nih.gov/pubmed/25834420 http://dx.doi.org/10.2147/COPD.S77144

Ejemplares similares

Clinical Determinants of Successful Omalizumab Therapy in Severe Allergic Asthma Patients: 4-Year-Long, Real-Life Observation
por: Kucharczyk, Aleksandra, et al.
Publicado: (2020)

Tiotropium in asthma: back to the future of anticholinergic treatment
por: Bonini, Matteo, et al.
Publicado: (2017)

Relevance of dosage in adherence to treatment with long-acting anticholinergics in patients with COPD
por: Izquierdo, José Luis, et al.
Publicado: (2016)

Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators
por: Nicolini, Antonello
Publicado: (2012)

Facilitated Subcutaneous Immunoglobulin Replacement Therapy in Clinical Practice: A Two Center, Long-Term Retrospective Observation in Adults With Primary Immunodeficiencies
por: Wiesik-Szewczyk, Ewa, et al.
Publicado: (2020)

Role of tiotropium in the treatment of COPD
por: Rice, Kathryn L, et al.
Publicado: (2007)

Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
por: Li, Chenglong, et al.
Publicado: (2019)

The development of anticholinergics in the management of COPD
por: Scullion, Jane E
Publicado: (2007)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2016)

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide
por: Price, David, et al.
Publicado: (2015)

Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis
por: Muro, Shigeo, et al.
Publicado: (2019)

Tiotropium/Olodaterol: A Review in COPD
por: Blair, Hannah A.
Publicado: (2019)

A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2018)

From infections to autoimmunity: Diagnostic challenges in common variable immunodeficiency
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2020)

Safety and tolerability of inhalational anticholinergics in COPD
por: Sharafkhaneh, Amir, et al.
Publicado: (2013)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
por: Ichinose, Masakazu, et al.
Publicado: (2018)

Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials
por: Cooper, Christopher B, et al.
Publicado: (2011)

Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?
por: Price, David, et al.
Publicado: (2014)

Correction to: Tiotropium/Olodaterol: A Review in COPD
por: Blair, Hannah A.
Publicado: (2019)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]
Publicado: (2018)

Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
por: Lan, Ying, et al.
Publicado: (2023)

Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score–matched cohort analysis
por: Muro, Shigeo, et al.
Publicado: (2021)

Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients
por: Gorup, Eva, et al.
Publicado: (2018)

Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma
por: Santamaria, Francesca, et al.
Publicado: (2022)

Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD
por: Maltais, François, et al.
Publicado: (2019)

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study
por: Sauer, Rüdiger, et al.
Publicado: (2016)

Effect of add-on therapy of tiotropium in COPD treated with theophylline
por: Kawayama, Tomotaka, et al.
Publicado: (2008)

Socioeconomic gradients in tiotropium use among adults with COPD
por: Blanc, Paul D, et al.
Publicado: (2008)

The effect of tiotropium therapy on markers of elastin degradation in COPD
por: Ma, Shuren, et al.
Publicado: (2009)

Safety, tolerability and risk benefit analysis of tiotropium in COPD
por: Oba, Yuji, et al.
Publicado: (2008)

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
por: Derom, Eric, et al.
Publicado: (2016)

Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study
por: Ishiura, Yoshihisa, et al.
Publicado: (2022)

Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO(®) Trials
por: Rabe, Klaus F., et al.
Publicado: (2020)

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD
por: Tonnel, A-B, et al.
Publicado: (2008)

Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
por: Hamelmann, Eckard
Publicado: (2018)

Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in Poland
por: Jahnz-Różyk, Karina, et al.
Publicado: (2018)

Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome persisting to adulthood – an example of a diagnostic and therapeutic challenge
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2019)

Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
por: Singh, Dave, et al.
Publicado: (2016)

Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions
por: Neyt, Mattias, et al.
Publicado: (2010)

Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study
por: Kaplan, Alan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fbn8iea5v0ojtohk6puebbokfq